Cardiac arrhythmias and conduction abnormalities in patients with type 2 diabetes

[1]  J. Tamargo.  Faculty Opinions recommendation of Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus: Insights From the DECLARE-TIMI 58 Trial. , 2020, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.

[2]  A. Rosengren,et al.  Risk of atrial fibrillation in persons with type 2 diabetes and the excess risk in relation to glycaemic control and renal function: a Swedish cohort study , 2020, Cardiovascular Diabetology.

[3]  Björn Eliasson,et al.  Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes , 2018, The New England journal of medicine.

[4]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[5]  S. Santos,et al.  Obesity and malnutrition similarly alter the renin-angiotensin system and inflammation in mice and human adipose. , 2017, The Journal of nutritional biochemistry.

[6]  N. Kalupahana,et al.  Regulation and Functions of the Renin-Angiotensin System in White and Brown Adipose Tissue. , 2017, Comprehensive Physiology.

[7]  Björn Eliasson,et al.  Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes , 2017, The New England journal of medicine.

[8]  A. Schjerning,et al.  Risk of atrial fibrillation in diabetes mellitus: A nationwide cohort study , 2016, European journal of preventive cardiology.

[9]  V. Somers,et al.  Effects of Atorvastatin (80 mg) Therapy on Quantity of Epicardial Adipose Tissue in Patients Undergoing Pulmonary Vein Isolation for Atrial Fibrillation. , 2015, The American journal of cardiology.

[10]  Christopher X. Wong,et al.  Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort: A Long-Term Follow-Up Study (LEGACY). , 2015, Journal of the American College of Cardiology.

[11]  S. Rabkin,et al.  Comparison of reducing epicardial fat by exercise, diet or bariatric surgery weight loss strategies: a systematic review and meta‐analysis , 2015, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[12]  R. Mahajan,et al.  Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study. , 2014, Journal of the American College of Cardiology.

[13]  W. Abhayaratna,et al.  Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial. , 2013, JAMA.

[14]  Shih-Yi Lin,et al.  Effects of weight loss on epicardial adipose tissue thickness and its relationship between serum soluble CD40 ligand levels in obese men. , 2013, Clinica chimica acta; international journal of clinical chemistry.

[15]  A. Stillman,et al.  Effect of Intensive Versus Moderate Lipid-Lowering Therapy on Epicardial Adipose Tissue in Hyperlipidemic Post-Menopausal Women , 2013 .

[16]  J. Ludvigsson,et al.  External review and validation of the Swedish national inpatient register , 2011, BMC public health.

[17]  A. Folsom,et al.  Metabolic syndrome and incidence of atrial fibrillation among blacks and whites in the Atherosclerosis Risk in Communities (ARIC) Study. , 2010, American heart journal.

[18]  J. Hare,et al.  Effects of weight loss after bariatric surgery on epicardial fat measured using echocardiography. , 2007, The American journal of cardiology.

[19]  P A Wolf,et al.  Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. , 1998, The American journal of cardiology.

[20]  D. Leosco,et al.  Statin therapy modulates thickness and inflammatory profile of human epicardial adipose tissue. , 2019, International journal of cardiology.

[21]  J. Beckman,et al.  Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II. , 2013, European heart journal.

[22]  D. Dey,et al.  Weight change modulates epicardial fat burden: a 4-year serial study with non-contrast computed tomography. , 2012, Atherosclerosis.

[23]  E. Glaser.  The randomized clinical trial. , 1972, The New England journal of medicine.